On CNBC’s “Halftime Report Final Trades,” Jim Lebenthal of Cerity Partners named Berkshire Hathaway Inc. (NYSE:BRK) as his final trade ahead of its quarterly earnings report on Saturday.
On April 25, UBS analyst Brian Meredith maintained a Buy rating for Berkshire Hathaway and raised the price target from $557 to $606.
Stephen L. Weiss of Short Hills Capital Partners picked Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) as his final trade.
Lending support to his choice, Cantor Fitzgerald analyst Carter Gould, on April 22, initiated coverage …
Full story available on Benzinga.com
On CNBC’s “Halftime Report Final Trades,” Jim Lebenthal of Cerity Partners named Berkshire Hathaway Inc. (NYSE:BRK) as his final trade ahead of its quarterly earnings report on Saturday.
On April 25, UBS analyst Brian Meredith maintained a Buy rating for Berkshire Hathaway and raised the price target from $557 to $606.
Stephen L. Weiss of Short Hills Capital Partners picked Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) as his final trade.
Lending support to his choice, Cantor Fitzgerald analyst Carter Gould, on April 22, initiated coverage …
Full story available on Benzinga.com
On CNBC’s “Halftime Report Final Trades,” Jim Lebenthal of Cerity Partners named Berkshire Hathaway Inc. (NYSE:BRK) as his final trade ahead of its quarterly earnings report on Saturday.
On April 25, UBS analyst Brian Meredith maintained a Buy rating for Berkshire Hathaway and raised the price target from $557 to $606.
Stephen L. Weiss of Short Hills Capital Partners picked Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) as his final trade.
Lending support to his choice, Cantor Fitzgerald analyst Carter Gould, on April 22, initiated coverage …Full story available on Benzinga.com Read MoreBRK, CME, CNBC, Halftime Report Final Trades, Jim Lebenthal, Joseph M. Terranova, Karen Firestone, Long Ideas, News, SPGI, Stephen L. Weiss, VRTX, Markets, Media, Trading Ideas, CME, US12572Q1058, VRTX, US92532F1003, BRK, SPGI, Long Ideas, News, Markets, Media, Trading Ideas, Benzinga Markets
